Dr Omar Aiyash, | |
2020 Ogden Ave Ste 400, Aurora, IL 60504-5898 | |
(630) 692-5563 | |
(630) 692-5564 |
Full Name | Dr Omar Aiyash |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 9 Years |
Location | 2020 Ogden Ave Ste 400, Aurora, Illinois |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295186492 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 036149059 (Illinois) | Primary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Dmj Home Health Services, Inc | Aurora, IL | Home health agency |
Copley Memorial Hospital | Aurora, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rush-copley Medical Group Nfp | 7618864877 | 108 |
News Archive
A joint study by Indiana University and Columbia University researchers found no change in prejudice and discrimination toward people with serious mental illness or substance abuse problems despite a greater embrace by the public of neurobiological explanations for these illnesses.
Data show that Boehringer Ingelheim's second-generation protease inhibitor faldaprevir, when used in combination with pegylated interferon and ribavirin, was effective even with the presence of naturally-occurring mutant variants of the hepatitis C virus, such as the NS3 Q80K polymorphism
Ontario children are more likely to get diagnosed with diabetes than their American counterparts. A study out of the Institute for Clinical Evaluative Sciences (ICES) has found a 3 per cent increase per year in the rate of diabetes in Ontario children from 1994 to 2004.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
› Verified 4 days ago
Entity Name | Rush-copley Medical Group Nfp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093075848 PECOS PAC ID: 7618864877 Enrollment ID: O20040310001029 |
News Archive
A joint study by Indiana University and Columbia University researchers found no change in prejudice and discrimination toward people with serious mental illness or substance abuse problems despite a greater embrace by the public of neurobiological explanations for these illnesses.
Data show that Boehringer Ingelheim's second-generation protease inhibitor faldaprevir, when used in combination with pegylated interferon and ribavirin, was effective even with the presence of naturally-occurring mutant variants of the hepatitis C virus, such as the NS3 Q80K polymorphism
Ontario children are more likely to get diagnosed with diabetes than their American counterparts. A study out of the Institute for Clinical Evaluative Sciences (ICES) has found a 3 per cent increase per year in the rate of diabetes in Ontario children from 1994 to 2004.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
› Verified 4 days ago
Entity Name | Copley Memorial Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619466034 PECOS PAC ID: 4587656921 Enrollment ID: O20180530001537 |
News Archive
A joint study by Indiana University and Columbia University researchers found no change in prejudice and discrimination toward people with serious mental illness or substance abuse problems despite a greater embrace by the public of neurobiological explanations for these illnesses.
Data show that Boehringer Ingelheim's second-generation protease inhibitor faldaprevir, when used in combination with pegylated interferon and ribavirin, was effective even with the presence of naturally-occurring mutant variants of the hepatitis C virus, such as the NS3 Q80K polymorphism
Ontario children are more likely to get diagnosed with diabetes than their American counterparts. A study out of the Institute for Clinical Evaluative Sciences (ICES) has found a 3 per cent increase per year in the rate of diabetes in Ontario children from 1994 to 2004.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Omar Aiyash, 2020 Ogden Ave Ste 400, Aurora, IL 60504-5898 Ph: (630) 692-5563 | Dr Omar Aiyash, 2020 Ogden Ave Ste 400, Aurora, IL 60504-5898 Ph: (630) 692-5563 |
News Archive
A joint study by Indiana University and Columbia University researchers found no change in prejudice and discrimination toward people with serious mental illness or substance abuse problems despite a greater embrace by the public of neurobiological explanations for these illnesses.
Data show that Boehringer Ingelheim's second-generation protease inhibitor faldaprevir, when used in combination with pegylated interferon and ribavirin, was effective even with the presence of naturally-occurring mutant variants of the hepatitis C virus, such as the NS3 Q80K polymorphism
Ontario children are more likely to get diagnosed with diabetes than their American counterparts. A study out of the Institute for Clinical Evaluative Sciences (ICES) has found a 3 per cent increase per year in the rate of diabetes in Ontario children from 1994 to 2004.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
› Verified 4 days ago
Joseph Robert Rojas, Family Medicine Medicare: Medicare Enrolled Practice Location: 2020 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4850 Fax: 630-978-6865 | |
Jurate Kunickaite, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6859 | |
Daniel E Hrad, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4205 Westbrook Dr, Aurora, IL 60504 Phone: 630-527-1818 Fax: 630-527-1244 | |
Aruna Galla-pagadala, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 | |
Kuchipudi Veerraju, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 475 N Farnsworth Ave, Aurora Medical Clinic, Aurora, IL 60505 Phone: 630-898-0022 Fax: 630-898-2933 | |
Dr. Robert D. Paras, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2111 Ogden Ave, Aurora, IL 60504 Phone: 630-978-3800 Fax: 630-862-3085 | |
Dr. Mona Habiba Waheed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 |